FR2356419A1 - Myorelaxant sans effet depolarisant - Google Patents
Myorelaxant sans effet depolarisantInfo
- Publication number
- FR2356419A1 FR2356419A1 FR7619643A FR7619643A FR2356419A1 FR 2356419 A1 FR2356419 A1 FR 2356419A1 FR 7619643 A FR7619643 A FR 7619643A FR 7619643 A FR7619643 A FR 7619643A FR 2356419 A1 FR2356419 A1 FR 2356419A1
- Authority
- FR
- France
- Prior art keywords
- relaxants
- tercuronium
- dibenzenesulphonate
- bis
- tubocurarine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003156 neuromuscular nondepolarizing agent Substances 0.000 title abstract 2
- PNUIGXZFFGMREY-UHFFFAOYSA-N triethyl-[4-[4-[4-(triethylazaniumyl)phenyl]phenyl]phenyl]azanium Chemical compound C1=CC([N+](CC)(CC)CC)=CC=C1C1=CC=C(C=2C=CC(=CC=2)[N+](CC)(CC)CC)C=C1 PNUIGXZFFGMREY-UHFFFAOYSA-N 0.000 title abstract 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 2
- 230000000903 blocking effect Effects 0.000 abstract 2
- 230000002232 neuromuscular Effects 0.000 abstract 2
- 229960005457 pancuronium Drugs 0.000 abstract 2
- GVEAYVLWDAFXET-XGHATYIMSA-N pancuronium Chemical compound C[N+]1([C@@H]2[C@@H](OC(C)=O)C[C@@H]3CC[C@H]4[C@@H]5C[C@@H]([C@@H]([C@]5(CC[C@@H]4[C@@]3(C)C2)C)OC(=O)C)[N+]2(C)CCCCC2)CCCCC1 GVEAYVLWDAFXET-XGHATYIMSA-N 0.000 abstract 2
- 229960001844 tubocurarine Drugs 0.000 abstract 2
- JFJZZMVDLULRGK-URLMMPGGSA-O tubocurarine Chemical compound C([C@H]1[N+](C)(C)CCC=2C=C(C(=C(OC3=CC=C(C=C3)C[C@H]3C=4C=C(C(=CC=4CCN3C)OC)O3)C=21)O)OC)C1=CC=C(O)C3=C1 JFJZZMVDLULRGK-URLMMPGGSA-O 0.000 abstract 2
- 206010043376 Tetanus Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960003054 gallamine Drugs 0.000 abstract 1
- ICLWTJIMXVISSR-UHFFFAOYSA-N gallamine Chemical compound CCN(CC)CCOC1=CC=CC(OCCN(CC)CC)=C1OCCN(CC)CC ICLWTJIMXVISSR-UHFFFAOYSA-N 0.000 abstract 1
- 229960001340 histamine Drugs 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- ALWKGYPQUAPLQC-UHFFFAOYSA-N neostigmine Chemical compound CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 ALWKGYPQUAPLQC-UHFFFAOYSA-N 0.000 abstract 1
- 229960002362 neostigmine Drugs 0.000 abstract 1
- 210000000653 nervous system Anatomy 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 238000009423 ventilation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7619643A FR2356419A1 (fr) | 1976-06-28 | 1976-06-28 | Myorelaxant sans effet depolarisant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7619643A FR2356419A1 (fr) | 1976-06-28 | 1976-06-28 | Myorelaxant sans effet depolarisant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2356419A1 true FR2356419A1 (fr) | 1978-01-27 |
| FR2356419B1 FR2356419B1 (enExample) | 1978-12-15 |
Family
ID=9174939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7619643A Granted FR2356419A1 (fr) | 1976-06-28 | 1976-06-28 | Myorelaxant sans effet depolarisant |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2356419A1 (enExample) |
-
1976
- 1976-06-28 FR FR7619643A patent/FR2356419A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2356419B1 (enExample) | 1978-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brodkey et al. | Reversible spinal cord trauma in cats: additive effects of direct pressure and ischemia | |
| Ollendick et al. | Overcorrection: An overview. | |
| MD1432B2 (en) | Method of treatment of the state depending on the ovarian estrogens | |
| Downing | Baroreceptor reflexes in new-born rabbits | |
| WO1991004058A3 (en) | Treatment of conditions and disease | |
| ES459938A1 (es) | Procedimiento para obtener una composicion farmaceutica en forma de un gel de polimero carboxivinilico, para insercion en el cuerpo | |
| JPS6470415A (en) | Skin permeable remedy system | |
| Fisch et al. | The surgical treatment of facial hyperkinesia | |
| Lipton et al. | Pituitary injection of alcohol for widespread cancer pain | |
| Levy | Studies on the Conditions of Activity in Endocrine Glands: IV. The effect of Thyroid Secretion on the Pressor Action of Adrenin | |
| Needles | The auriculotemporal syndrome: with a suggestion regarding therapy | |
| FR2356419A1 (fr) | Myorelaxant sans effet depolarisant | |
| Ware et al. | Cervical esophagostomy: a simplified technic | |
| AR003979A1 (es) | Administracion transdermica de vorozol. | |
| Wilkerson et al. | Ventricular arrhythmias produced by coronary artery occlusion in closed-chest dogs | |
| JPS51118841A (en) | A drug for improving and treating clouding of consciousness | |
| Burton | Cat sartorius muscle: an isolated perfused skeletal muscle preparation for microvascular research | |
| Macleod et al. | Tissue metabolism of brain cortex and liver after hypophysectomy and treatment with thyrotrophic hormone | |
| Gramstad et al. | Effect of ionized calcium on the neuromuscular blocking actions of atracurium and vecuronium in the cat | |
| Sealy et al. | Effect of quinidine on ventricular fibrillation in hypothermic dogs. | |
| Phemister | Role of the nervous system in shock | |
| Pauls et al. | Production of diabetes in the mouse by partial pancreatectomy | |
| Bombeck et al. | Antral reactivity: effect of vagal innervation on antral gastrin release by various stimuli | |
| Halmagyi et al. | Course of posthemorrhagic hypotension after celiac ganglionectomy with and without adrenal denervation | |
| Rosell et al. | The functional state of vasomotor nerves to skeletal muscle vessels in reserpinized cats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |